Sarah Kathryn Rouan

Insider Reports History

Entity
Individual
Location
4995 Bradenton Avenue, Suite 240, Dublin, OH
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah Kathryn Rouan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NAVIDEA BIOPHARMACEUTICALS, INC. Director Common Stock 18.2K $1.61K $0.09 Jun 30, 2021 Direct
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 0 $0 $80.89 Oct 25, 2024 Direct
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 0 $0 $28.05 Feb 8, 2024 Direct
Viking Therapeutics, Inc. Director Stock Option (Right to Buy) 11K Oct 25, 2024 Direct

Insider Reports Filed by Sarah Kathryn Rouan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VKTX Viking Therapeutics, Inc. Oct 25, 2024 3 -$836K 4 Oct 25, 2024 Director
VKTX Viking Therapeutics, Inc. Feb 8, 2024 3 -$493K 4 Feb 8, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 19, 2024 3 -$442K 4 Jan 19, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Jun 30, 2021 1 $0 4 Jul 7, 2021 Director